SRHQ SRH U.S. Quality GARP ETF

Expense Ratio
0.35%
Dividend
0.75%
Previous close
$41.34
Est. 12 months change
+13.55%
Projected Price
$46.94

Profitability Metrics

Return on Equity (ROE)
33.56%
Return on Assets (ROA)
6.91%
Return on Invested Capital (ROIC)
22.20%
Weighted Average Cost of Capital (WACC)
8.04%
ROIC - WACC
14.16%
Updated : 2026-04-04 08:09 ET

Valuation Metrics

P/E Ratio
23.04
Forward P/E
16.53
PEG Ratio
1.76
Debt Current Ratio
1.79

Growth & Cash Flow

Gross Margin
40.97%
Operating Margin
15.14%
FCF Margin
16.13%
TTM Revenue Growth
10.79%
Projected 12M EPS Growth
39.39%

Price Change

Price % from 50 SMA
1.37%
Price % from 200 SMA
5.54%
6 Months
5.99%
1 Year
13.98%
2 Years
19.72%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
CIEN9.37%
EME2.94%
ENS2.83%
JBL2.82%
KEYS2.79%
NYT2.60%
PLXS2.34%
CAH2.32%
WTS2.16%
COKE2.14%

ETF Analysis

Fund Overview

SRH U.S. Quality GARP ETF (SRHQ) currently reports 60 stock positions (subject to change), placing it in the moderately spread range by holdings breadth. The top line-up is CIEN (9.37%), EME (2.94%), ENS (2.83%), with CIEN as the largest single weight at 9.37%. Together, the top three holdings account for 15.14%, which does not represent a dominant share, indicating less concentration in the very top of the book. The overall construction balances concentrated exposure at the top with broader diversification through the rest of the book.

Profitability & Capital Efficiency

Through the lens of capital efficiency, ROIC is 22.20%, WACC is 8.04%, and the economic spread is 14.16%. On balance, the gap between operating returns and funding costs is healthy, pointing to businesses with genuine pricing and reinvestment advantages. Supporting metrics show ROE at 33.56% and ROA at 6.91%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Assessed on a multiple basis, trailing P/E of 23.04, forward P/E of 16.53, PEG of 1.76. Forward P/E comes in somewhat below trailing — a gap that is supportive of the valuation case without implying a sharp near-term earnings inflection. Growth-adjusted, the multiple is in an acceptable range — the portfolio is neither pricing in perfection nor offering a meaningful valuation discount. The portfolio's weighted current ratio of 1.79 reflects adequate near-term financial stability. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.

Margins & Cash Generation

The margin profile breaks down as follows: gross margin sits at 40.97%, operating margin at 15.14%, and free cash flow margin at 16.13%. Gross margins are in good shape, suggesting the holdings maintain pricing discipline at the revenue-to-cost interface. Operating margins are solid, reflecting adequate cost control relative to the revenue base. The portfolio's FCF margin is healthy, indicating solid cash conversion after capital expenditure needs. The mixed margin profile here calls for selectivity — the portfolio's quality of earnings is not uniform across the holding set.

Growth & Forward Outlook

The near-term directional case rests on two inputs: TTM revenue growth of 10.79% pointing to reasonable revenue execution across the underlying holdings. In parallel, analysts project moderate appreciation over the next 12 months based on current consensus targets. The two figures measure different things — one reflects what businesses are actually delivering, the other what the market expects them to deliver. The extent to which these signals converge or diverge will likely be a primary driver of realized returns relative to current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

The data points reviewed collectively point toward a positive outcome if execution holds — the setup is favorable even accounting for the inherent uncertainty in forward estimates.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.